Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

被引:36
|
作者
Kristensen, Soren L. [1 ,2 ]
Jhund, Pardeep S. [1 ]
Kober, Lars [3 ]
Preiss, David [1 ]
Kjekshus, John [4 ]
McKelvie, Robert S. [5 ]
Zile, Michael R. [6 ,7 ]
Anand, Inder S. [8 ,9 ]
Wikstrand, John [10 ]
Wedel, Hans [11 ]
Komajda, Michel [12 ,13 ]
Carson, Peter E. [14 ,15 ]
Cleland, John G. F. [16 ,17 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
[5] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[6] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Vet Affairs Med Ctr, Minneapolis, MN USA
[9] Univ Minnesota, Minneapolis, MN USA
[10] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden
[11] Nord Sch Publ Hlth, Gothenburg, Sweden
[12] Univ Paris 06, Hosp Pitie Salpetriere, Paris, France
[13] Inst ICAN, Paris, France
[14] Georgetown Univ, Washington, DC USA
[15] Washington DC Vet Affairs Med Ctr, Washington, DC USA
[16] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[17] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst, London, England
关键词
Heart failure; Clinical trials; HF-PEF; HF-REF; Mortality; ROSUVASTATIN; TRIAL; PROGRESSION; IRBESARTAN; DESIGN; CORONA;
D O I
10.1002/ejhf.211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo investigate the prognostic significance of hospitalization for worsening heart failure (WHF), myocardial infarction (MI), and stroke in patients with chronic heart failure (HF). Methods and resultsWe studied 5011 patients with HF and reduced EF (HF-REF) in the CORONA trial and 4128 patients with HF and preserved EF (HF-PEF) in the I-Preserve trial. Adjusted hazard ratios (HRs) for death were estimated for 0-30 days and 31 days after first post-randomization WHF, MI, or stroke used as a time-dependent variable, compared with patients with none of these events. In CORONA, 1616 patients (32%) had post-randomization first events (1223 WHF, 216 MI, 177 stroke), and the adjusted HR for mortality 30 days after an event was: WHF 7.21 [95% confidence interval (CI) 2.05-25.40], MI 23.08 (95% CI 6.44-82.71), and stroke 32.15 (95% CI 8.93-115.83). The HR for mortality at >30 days was: WHF 3.62 (95% CI 3.11-4.21), MI 4.41 (95% CI 3.23-6.02), and stroke 3.19 (95% CI 2.21-4.61). In I-Preserve, 896 patients (22%) experienced a post-randomization event (638 WHF, 111 MI, 147 stroke). The HR for mortality 30 days was WHF 31.77 (95% CI 7.60-132.81), MI 154.77 (95% CI 34.21-700.17), and stroke 223.30 (95% CI 51.42-969.78); for >30 days it was WHF 3.36 (95% CI 2.79-4.05), MI 3.29 (95% CI 2.14-5.06), and stroke 5.13 (95% CI 3.61-7.29). ConclusionsIn patients with both HF-REF and HF-PEF, hospitalization for WHF was associated with high early and late mortality. The early relative risk of death was not as great as following MI or stroke, but the longer term relative risk of death was similar following all three types of event. Numerically, more deaths occurred following WHF because it was a much more common event.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [21] Statins Beneficial for Heart Failure With Preserved Ejection Fraction But Not Heart Failure With Reduced Ejection Fraction?
    Ohte, Nobuyuki
    Little, William C.
    CIRCULATION JOURNAL, 2015, 79 (03) : 508 - 509
  • [22] COMPARISON OF BETA BLOCKER EFFECTIVENESS AFTER HEART FAILURE HOSPITALIZATION IN PATIENTS WITH PRESERVED EJECTION FRACTION VS. THOSE WITH REDUCED EJECTION FRACTION
    El-Refai, Mostafa
    Peterson, Edward
    Wells, Karen
    Swadia, Tanmay
    Spertus, John
    Williams, Keoki
    Lanfear, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E884 - E884
  • [23] Characteristics and Outcomes of Worsening Left Ventricular Ejection Fraction in Heart Failure Patients With Preserved Ejection Fraction.
    Oikawa, Masayoshi
    Yoshihisa, Akiomi
    Ichijyo, Yasuhiro
    Kiko, Takatoyo
    Kimishima, Yusuke
    Sato, Yu
    Kanno, Yuki
    Takiguchi, Mai
    Yokokawa, Tetsuro
    Abe, Satoshi
    Misaka, Tomofumi
    Sato, Takamasa
    Kobayashi, Atsushi
    Yamaki, Takayoshi
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Ishida, Takafumi
    Takeishi, Yasuchika
    CIRCULATION, 2018, 138
  • [24] Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction
    Kajimoto, Katsuya
    Minami, Yuichiro
    Sato, Naoki
    Kasanuki, Hiroshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (12): : 1881 - 1887
  • [25] Comparison of Perioperative Outcomes in Heart Failure Patients With Reduced Versus Preserved Ejection Fraction After Noncardiac Surgery
    Huang, Yolanda Ya-Chin
    Chen, Ling
    Wright, Jason D.
    ANNALS OF SURGERY, 2022, 275 (04) : 807 - 815
  • [26] Comparison of Outcomes After Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction
    Aldaas, Omar M.
    Malladi, Chaitanya L.
    Mylavarapu, Praneet S.
    Lupercio, Florentino
    Darden, Douglas
    Han, Frederick T.
    Hoffmayer, Kurt S.
    Krummen, David
    Ho, Gordon
    Raissi, Farshad
    Feld, Gregory K.
    Hsu, Jonathan C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 136 : 62 - 70
  • [27] First and Repeat Episodes of Worsening Heart Failure in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction: An Analysis of Deliver
    Jhund, Pardeep S.
    Claggett, Brian
    Talebi, Atefeh
    Gasparyan, Samvel
    Butt, Jawad
    Wilderang, Ulrica
    Vaduganathan, Muthiah
    Desai, Akshay S.
    De Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S.
    Martinez, Felipe
    Shah, Sanjiv J.
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna Maria
    Solomon, Scott D.
    McMurray, John J.
    CIRCULATION, 2022, 146 (25) : E586 - E586
  • [28] Duration of heart failure and outcomes in patients with heart failure and reduced ejection fraction
    Tomer, M. Meenakshi
    Gannuscio, J.
    Valentova, M.
    Fonarow, G.
    Adamopoulos, C.
    Kanonidis, I.
    Deedwania, P.
    Aronow, W.
    Anker, S.
    Ahmed, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 196 - 197
  • [29] Comparison of Clinical Outcomes of Patients With Acute Heart Failure and Recovered Ejection Fraction versus Preserved or Reduced Ejection Fraction
    Cho, Jae Yeong
    Kim, Kye Hun
    Lee, Sang Eun
    Cho, Hyun Jai
    Lee, Hae-Yeoung
    Choi, Jin-Oh
    Jeon, Eun-Seok
    Kim, Min-Seok
    Kim, Jae-Joong
    Hwang, Kyung-Kuk
    Chae, Shung Chull
    Baek, Sang Hong
    Kang, Seok-Min
    Choi, Dong-Ju
    Yoo, Byung-Su
    Ahn, Youngkeun
    Park, Hyun-Young
    Cho, Myeong-Chan
    Oh, Byung-Hee
    CIRCULATION, 2017, 136
  • [30] Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot
    Tan, Christianne
    Diem Dinh
    Brennan, Angela
    Hare, David L.
    Kaye, David
    Lefkovits, Jeffrey
    Lockwood, Siobhan
    Neil, Christopher
    Prior, David
    Nasis, Arthur
    Wilson, Andrew
    Reid, Christopher M.
    Stub, Dion
    Driscoll, Andrea
    HEART LUNG AND CIRCULATION, 2022, 31 (05): : 623 - 628